Bin Yao
Ningbo, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
AdvanTIG-301: a phase III study of ociperlimab plus tislelizumab and concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer.
Journal: Journal for immunotherapy of cancer
Published: July 28, 2026
Retraction Note: A novel necroptosis signature for predicting survival in lung adenocarcinoma.
Journal: BMC medical genomics
Published: October 16, 2024
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial.
Journal: The Lancet. Respiratory medicine
Published: April 04, 2024
A novel necroptosis signature for predicting survival in lung adenocarcinoma.
Journal: BMC medical genomics
Published: June 05, 2023
Effect of the hospital-community-family (HCF) nutritional management on patients with esophageal and head and neck cancers undergoing radiotherapy: a randomized control trial.
Journal: Translational cancer research
Published: October 18, 2022
Pyrotinib in the treatment of advanced lung adenocarcinoma with HER2 exon 20 mutation: a case report and literature review.
Journal: Annals of palliative medicine
Published: October 26, 2021
Acquired ALK Resistance Mutations Identified from Liquid Biopsy in an ALK-Rearranged Squamous Cell Lung Cancer Patient Treated with Sequential ALK TKI Therapy: A Case Report.
Journal: OncoTargets and therapy
Published: April 14, 2021
Early Onset Immune-Related Adverse Event to Identify Pseudo-Progression in a Patient With Ovarian Cancer Treated With Nivolumab: A Case Report and Review of the Literature.
Journal: Frontiers in medicine
Published: December 17, 2019
Molecular genetic characterization reveals linear tumor evolution in a pulmonary sarcomatoid carcinomas patient with a novel PHF20-NTRK1 fusion: a case report.
Journal: BMC cancer
Published: February 09, 2018
Krüppel-Like Factor 4 Inhibits Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis by Down-Regulating Caveolin-1 Expression.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: July 24, 2017
miR-509-3-5P inhibits the invasion and lymphatic metastasis by targeting PODXL and serves as a novel prognostic indicator for gastric cancer.
Journal: Oncotarget
Published: February 17, 2017
Last Updated: 09/26/2026